Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKrm22 Plc Regulatory News (KRM)

Share Price Information for Krm22 Plc (KRM)

Share Price is delayed by 15 minutes
Get Live Data
32.50    0.00 (0.00%)
Bid:
32.00
Ask:
33.00
Spread: 1.00 (3.125%)
Market Cap: £19.28m
KRM Live PriceLast checked at - London Stock Exchange

Intraday Krm22 Plc Share Chart

Half Year Trading Update

11 Jul 2019 07:00

RNS Number : 1574F
KRM22 PLC
11 July 2019
Β 

KRM22 plc

Β 

("KRM22" or the "Company")

Β 

Half Year Trading Update

Β 

KRM22 plc, (AIM: KRM) the technology and software investment company that focuses on risk management for capital markets, today issues the following trading update for the 6 months to 30 June 2019.

Β 

Key points:

Β· ARR increased to Β£4.1 million, a Β£0.8 million increase since year end 2018

Β· Global Risk Platform and Enterprise Risk Cockpit launched

Β· Acquisition of Object+ to provide a suite of "pre-trade" and "at trade" market risk applications

Β· 3 key partnerships signed to support the FCA's Senior Managers and Certification Regime ("SM&CR")

Β· 37 customers increased from 26 at year end 2018

Β 

The Company continues to perform in line with management expectations with Annual Recurring Revenue increasing to Β£4.1 million, an increase of Β£0.8 million (24%) since year end 2018. Β£0.5 million of this increase was achieved through the acquisition of Object+ in late May 2019, with the remaining Β£0.3 million of organic growth generated through new customer agreements. The sales pipeline is strong with contracts in negotiation and several proposals under active negotiation. The sales pipeline has been continuously building through the first half of the year as we released new offerings and submitted proposals. The second half of the year was always expected to be significantly bigger as we move forward into KRM22's second year of operation.

Β 

The Company was pleased that both the Global Risk Platform and the Enterprise Risk Cockpit launched in March 2019. In May, the Company announced the acquisition of Object+, a market risk management services technology business. In addition to this progress, the Company has signed partnership agreements with the Market Abuse Centre, Trailight and Neotas to support the FCA's SM&CR extension and bring further complimentary capabilities to the Global Risk Platform.

Β 

The Company continues to operate tight control of the cost base, both within current financial facilities and projected cashflows, which benefit from favourable commercial terms on new contract signings. Cash as at 30 June 2019 was Β£1.4m and term debt was Β£2.1m, which includes the initial drawdown from the Harbert facility signed in April 2019 and third-party shareholder loans provided to Irisium in 2018, not payable until 2023.

Β 

Keith Todd, Chairman and CEO at KRM22, commented: "I am proud of the progress we have already made, and the momentum with which we are entering the second half of the year. Our priority for H2 is to drive recurring revenue growth through our strong sales pipeline of cross-selling opportunities and by attracting new customers. We will continue to bring further applications to the Global Risk Platform through investments, acquisitions and partnerships. Our discussions with potential strategic industry investors continue which we aim to conclude in the second half of year."

Β 

Β 

For further information please contact:

Β 

KRM22 plc InvestorRelations@krm22.com

Keith Todd CBE, Executive Chairman and CEO

Kim Suter, CFO

Β 

finnCap Ltd (Nominated Adviser and Sole Broker) +44 (0)20 7220 0500

Carl Holmes / Kate Bannatyne / Matthew Radley

Β 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

Β 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' regulatory, market, technology and operations risk challenges and to manage their entire enterprise risk profile.

Β 

Capital markets companies' partner with KRM22 to optimize risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

Β 

KRM22 PLC is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

Β 

See more about KRM22 atΒ KRM22.com.

Β 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
TSTSFDFASFUSEEW
Date   Source Headline
26th May 20263:24 pmRNSHolding(s) in Company
26th May 20262:25 pmRNSHolding(s) in Company
22nd May 20267:00 amRNSDirector Dealings
20th May 202611:19 amRNSDirector Dealings
20th May 20267:00 amRNSNotice of AGM and Posting of Annual Report
13th May 20267:00 amRNSFinal Results
29th Jan 20267:00 amRNSTrading Update
7th Jan 20267:00 amRNSAppointment of Director
20th Nov 20254:12 pmRNSTR-1
11th Nov 20257:00 amRNSIssue of Equity
10th Nov 20259:28 amRNSHolding(s) in Company
5th Nov 20251:05 pmRNSResult of GM
15th Oct 20257:00 amRNSResult of Placing
14th Oct 20254:50 pmRNSProposed Placing and Subscription
17th Sep 20257:00 amRNSInterim Results
7th Aug 20257:00 amRNSTrading Update
21st Jul 20257:00 amRNSIssue of Equity
27th Jun 20252:10 pmRNSResult of AGM
6th Jun 20257:00 amRNSDirector Dealing
2nd Jun 20257:00 amRNSIssue of Restricted Stock Units
30th May 20257:00 amRNSNotice of AGM and Posting of Annual Report
21st May 20257:00 amRNSDirector Dealing
19th May 20257:00 amRNSFinal Results
29th Apr 20257:00 amRNSFacility Amendment
7th Apr 20257:00 amRNSNew Customer Contracts
1st Apr 20257:00 amRNSFacility Amendment
18th Mar 20257:00 amRNSIssue of Equity
4th Mar 20257:00 amRNSNew Customer Contract
13th Feb 20255:00 pmRNSDirector Dealing
22nd Jan 20257:00 amRNSTrading Update
10th Jan 20257:00 amRNSIssue of Equity
23rd Dec 20247:00 amRNSLoan Facility Amendment
15th Oct 20247:00 amRNSIssue of Equity
25th Sep 20247:00 amRNSInterim Results
3rd Sep 20247:00 amRNSChange of Registered Office
29th Aug 20247:00 amRNSNew Customer Contract
22nd Aug 202410:00 amRNSGrant of Options and Director/PDMR Shareholding
19th Aug 20247:00 amRNSIssue of Equity
18th Jul 20247:00 amRNSHalf Year Trading Update
21st Jun 202412:49 pmRNSResult of AGM
29th May 20247:00 amRNSNotice of AGM and Posting of Annual Report
22nd May 20247:00 amRNSFinal Results
16th Apr 20247:00 amRNSDirector Dealings
15th Apr 20247:00 amRNSNew Customer Contract
10th Apr 20247:00 amRNSIssue of Equity
7th Mar 20247:00 amRNSBoard Changes
21st Feb 20247:00 amRNSTrading Update
1st Dec 20237:00 amRNSIssue of Restricted Stock Units
26th Sep 20237:00 amRNSInterim Results
27th Jul 202311:48 amRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.